Clinical Trials

Clinical Trial Detail

Return to search results.

A Phase 1 Study of LY2787106 in Cancer and Anemia

Complete title: A Phase 1 Safety Study of LY2787106 in Patients with Cancer and Anemia

Research Study Number       20130992
Principal Investigator       Pamela Becker, MD, PhD
Phase       I

Look up trial at NIH

Research Study Description

This study will evaluate the safety LY2787106 in participants with cancer and anemia. It will also evaluate when LY2787106 can improve anemia. This study has two parts: Part A is a dose escalation evaluation. Part B is an evaluation of LY2787106 at a defined dose given with and without iron supplementation.

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number       20130992
Contact       Seattle Cancer Care Alliance Intake Office
Telephone       800-804-8824 / 206-288-1024

Hematologic Malignancies; Non-malignant Condition

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials